Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men

Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study

(2018) Charitha Gowda et al.   Open Forum Infectious Diseases

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

(2017) Patrick Ingiliz et al.   JOURNAL OF HEPATOLOGY

EASL Recommendations on Treatment of Hepatitis C 2016

(2017)   JOURNAL OF HEPATOLOGY

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

(2017) Marc Bourlière et al.   NEW ENGLAND JOURNAL OF MEDICINE

Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis

(2016) Daniel J. Smith et al.   BMC INFECTIOUS DISEASES

Acute hepatitis C in the Netherlands: characteristics of the epidemic in 2014

(2016) S.J. Hullegie et al.   CLINICAL MICROBIOLOGY AND INFECTION

Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions

(2016) Luisa Salazar-Vizcaya et al.   HEPATOLOGY

Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients

(2016) Lisa I. Backus et al.   HEPATOLOGY

Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia

(2016) Nick Scott et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients

(2016) Sebastiaan J. Hullegie et al.   JOURNAL OF HEPATOLOGY

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

(2016) Natasha K. Martin et al.   JOURNAL OF HEPATOLOGY

HCV epidemiology in high-risk groups and the risk of reinfection

(2016) Håvard Midgard et al.   JOURNAL OF HEPATOLOGY

Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study

(2016) E. B. Tapper et al.   JOURNAL OF VIRAL HEPATITIS

Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study

(2016) Brooke E Nichols et al.   LANCET INFECTIOUS DISEASES

Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands

(2016) Daniëla K. van Santen et al.   PLoS One

LP48 : SVR12 results after 12-weeks boceprevir, peginterferon and ribavirin in the dutch acute hepatitis C in HIV study (DAHHs)

(2015) S. Hullegie et al.   JOURNAL OF HEPATOLOGY

Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs

(2015) John W. Ward et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

(2015) Michael P. Curry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

(2015) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM)

(2015) Natasha K. Martin et al.   Current Opinion in HIV and AIDS

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

(2014) Margaret T. May et al.   AIDS

Stabilizing Incidence of Hepatitis C Virus Infection Among Men Who Have Sex With Men in Amsterdam

(2014) Joost W. Vanhommerig et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?

(2013) Anneke S. de Vos et al.   ADDICTION

Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM

(2013) Thomas C.S. Martin et al.   AIDS

Limited spread of hepatitis C among HIV-negative men who have sex with men in Stockholm, Sweden

(2013) A Blaxhult et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Cost-effective Screening for Acute Hepatitis C Virus Infection in HIV-Infected Men Who Have Sex With Men

(2012) Benjamin P. Linas et al.   CLINICAL INFECTIOUS DISEASES

UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS

(2012) Siok Swan Tan et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5

(2012) Richard Pitman et al.   VALUE IN HEALTH

Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM

(2011) Femke A.E. Lambers et al.   AIDS

Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection

(2010) Thijs JW van de Laar et al.   AIDS

Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men

(2010) E. C. Thomson et al.   GUT

Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis

(2010) Cornelis Boersma et al.   VALUE IN HEALTH

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

(2008) Hla-Hla Thein et al.   AIDS

Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV

(2008) Emma C Thomson et al.   AIDS